Back to Search
Start Over
Serum Levels of Intact Parathyroid Hormone Is a Prognostic Indicator of Dialyzed Patients: The Nishinomiya Study
- Source :
- Therapeutic Apheresis and Dialysis. 18:334-339
- Publication Year :
- 2013
- Publisher :
- Wiley, 2013.
-
Abstract
- Patients with chronic kidney disease on dialysis are at higher risk for cardiovascular disease (CVD), which is the greatest cause of mortality. The target range of serum intact parathyroid hormone (iPTH) for prognosis, 60 to 240 pg/mL, was recommended by the Japanese Society for Dialysis Therapy guidelines. To investigate the impact of this iPTH target on CVD, dialysis patients were enrolled. A total 287 participants were observed. At the start of the study, serum iPTH levels, routine laboratory parameters, and certain factors related to CVD were evaluated. A survival analysis (Kaplan-Meier curve) was used. After 10 years of follow-up, 19.2% of patients had CVD. The subjects were divided into three groups according to their iPTH level at baseline based on the target range of 60 to 240 pg/mL: Low, Middle, and High groups. CVD was more common in the High and Low groups compared to the Middle group. A lower risk of CVD was evident in the extended dialysis patients with a range of 60 to 240 pg/mL iPTH. Further studies are needed to evaluate the impact of the iPTH level on poor outcome.
- Subjects :
- medicine.medical_specialty
business.industry
medicine.medical_treatment
Intact parathyroid hormone
Hematology
Lower risk
Dialysis patients
Target range
medicine.disease
Gastroenterology
Endocrinology
Nephrology
Internal medicine
medicine
Middle group
business
Dialysis
Survival analysis
Kidney disease
Subjects
Details
- ISSN :
- 17449979
- Volume :
- 18
- Database :
- OpenAIRE
- Journal :
- Therapeutic Apheresis and Dialysis
- Accession number :
- edsair.doi...........3975520bf395f94e1212430a83fe0906